ANTI-CXCL13 ANTIBODIES AND METHODS OF USING THE SAME

Compositions and methods are provided for treating diseases associated with CXCL13 expression, including certain autoimmune diseases, inflammatory diseases, and cancers. In particular, anti-CXCL13 monoclonal antibodies have been developed to neutralize CXCL13.

Saved in:
Bibliographic Details
Main Authors PARIS, MARK, SMITH, ERNEST S, KLIMATCHEVA, EKATERINA
Format Patent
LanguageEnglish
Published 30.04.2013
Online AccessGet full text

Cover

More Information
Summary:Compositions and methods are provided for treating diseases associated with CXCL13 expression, including certain autoimmune diseases, inflammatory diseases, and cancers. In particular, anti-CXCL13 monoclonal antibodies have been developed to neutralize CXCL13.
Bibliography:Application Number: SG20130013735